<DOC>
	<DOCNO>NCT01626066</DOCNO>
	<brief_summary>Real-time detection cancer cell surgical removal tumor important . Currently tissue remove time surgery , remove tissue go pathology margin ( edge tissue ) examine see cancer cell present . This may take several day . Patients tissue positive ( cancer cell present ) margin may require additional therapy include surgery . The purpose study determine safe dose new image agent ( LUM015 ) , like fluorescent contrast agent dye , show tumor area surgery may help facilitate visualization tumor removal .</brief_summary>
	<brief_title>Cathepsin Activatable Fluorescent Probe</brief_title>
	<detailed_description />
	<mesh_term>Sarcoma</mesh_term>
	<criteria>18 year age old Diagnosis soft tissue sarcoma breast cancer patient schedule lumpectomy mastectomy . Subjects must schedule surgical resection tumor least 1 cm size . Performance status 0 1 Able read , understand sign inform consent form Must able willing follow study procedure instruction include possible overnight stay surgery Otherwise healthy except diagnosis cancer ALT , AST , total bilirubin within 1.5x institutional upper normal limit ; alkaline phosphatase within 2.5x institutional upper normal limit Serum creatinine 1.5 mg less ; creatinine clearance great 30 ml/min May previously receive preoperative external beam radiation therapy sarcoma Pregnant lactate Prolonged QT interval : correct QT interval ( QTc ) &gt; 480 msec Insulin dependent diabetes History anaphylactic reaction drug contrast agent Asthma medical management Uncontrolled high blood pressure Severe , active comorbidity Known substance addiction Sexually active willing/able use medically acceptable form contraception . Obesity define BMI body mass index great 35 kg/meter square . Atopy atopic syndrome Known AIDS Can take investigational drug within 30 day come onto study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>